Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Atherosclerosis Plus is Scopus-indexed (Q2, CiteScore 3.7), WoS SCIE, DOAJ. Published by Elsevier Ireland Ltd.
Checked against the index lists dated .
ISSN 2667-0895Verify ISSN ↗2667-0909Verify ISSN ↗
Publisher: Elsevier Ireland Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Cardiology and Cardiovascular Medicine | 168 / 409 | 59th | Q2 |
| Internal Medicine | 77 / 179 | 57th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2021–present, best quartile Q2, CiteScore 3.7.
Atherosclerosis Plus is Q2 in Cardiology and Cardiovascular Medicine (rank 168 of 409) and Q2 in Internal Medicine (rank 77 of 179), by CiteScore 2025.
Atherosclerosis Plus is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.7, which places it in quartile Q2 at the 59th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.723, quartile Q2, with an H-index of 57.
The publisher lists an article processing charge of about US$2,440 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Atherosclerosis Plus is published by Elsevier Ireland Ltd. Its print ISSN is 2667-0895 and its online ISSN is 2667-0909.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Atherosclerosis Plus has an h-index of 16 and a 2-year mean of 1.59 citations per paper (OpenAlex). Its Scopus CiteScore is 3.7, quartile Q2. On 2-year citations it ranks #166 of 398 Scopus journals in Cardiology and Cardiovascular Medicine.
Atherosclerosis Plus published 54 papers in 2025; its busiest recent year was 2022 with 56. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 94 research articles (2025–2026), authors are most often from United Kingdom (30.7%), China (12.2%) and United States (9.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.